Clinical Trials Logo

Clinical Trial Summary

The aim is to compare the percentage of the different SARS-CoV2 lineages that are detected in wastewater samples with matched clinical samples. About 1,400 swab samples from patients living in Nice were tested by Biogroup between Oct 19th and Oct 23rd (Week 43 of 2020). The sequence of 81 PCR positive samples, corresponding to all samples that were unambiguously assigned to one of the wastewater catchment areas and their lineage was determined. These values were compared to values measured in wastewater.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05041764
Study type Observational
Source Centre Hospitalier Universitaire de Nice
Contact
Status Completed
Phase
Start date October 1, 2020
Completion date November 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT06178822 - Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Recruiting NCT03818334 - Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies Phase 2/Phase 3
Completed NCT04637867 - COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Completed NCT05069623 - A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers Phase 1/Phase 2
Recruiting NCT04386460 - Covid-19 and Prevention of Malnutrition After Confinement by Dentists
Completed NCT04290780 - COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
Completed NCT04327180 - PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
Recruiting NCT04438629 - Evaluation of Immune Response in COVID-19 Patients
Active, not recruiting NCT05874713 - Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults Phase 2
Completed NCT03163628 - biomArkers to differeNtiate bacTerial From vIral iNfEctions N/A
Completed NCT04924842 - COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
Completed NCT04354155 - COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial Phase 2
Recruiting NCT05875961 - Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults Phase 1
Recruiting NCT06379061 - Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
Active, not recruiting NCT04481529 - COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
Recruiting NCT05090319 - Micro-hematology Analyzer for Viral/Bacterial Description
Not yet recruiting NCT04887233 - Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19) N/A
Completed NCT04754633 - Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines